Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure - COMPASS: Carperitide effects observed through monitoring dyspnea in acute decompensated heart failure study

Circulation Journal

Volumn 72, Issue 11, 2008, Pages 1777-1786

  Nomura, Fumihiro ^a   Kurobe, Nobushige ^a   Mori, Yoshihiro ^a   Hikita, Atsushi ^b   Kawai, Masanori ^b   Suwa, Mitsuru ^b   Okutani, Yukihiro ^a  

^a DAIICHI SANKYO CO   (Japan)

^b Chugai Pharmaceuticals Co Ltd   (Japan)

Author keywords

Acute heart failure syndrome; Atrial natriuretic factor; Carperitide; COMPASS; Multicenter study

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MORPHINE; NITRATE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPOTENSION; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 55449125393     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-0760     Document Type: Article

References (20)

1. Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes. Am J Cardiol 2005; 96(Suppl): 26G-31G.
2. Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 2005; 96(Suppl): 11G-17G.
3. Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
4. Japanese Circulation Society. Guidelines for Treatment of Acute Heart Failure. Japanese Circulation Society; 2006. Available from http://www.j-circ. or.jp/guideline/index.htm
5. O'Connor CM, Gattis WA, Uretsky BF, Adams KF Jr, McNulty SE, Grossman SH, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999; 138: 78-86.
6. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, et al; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 2002; 287: 1541-1547.
7. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, Le Jemtel TH, et al; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46: 57-64.
8. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Colucci WS, et al. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 2003; 92: 136-138.
9. Kangawa K, Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984; 118: 131-139.
10. Kitashiro S, Sugiura T, Takayama Y, Tsuka Y, Izuoka T, Tokunaga S, et al. Long-term administration of atrial natriuretic peptide in patients with acute heart failure. J Cardiovasc Pharmacol 1999; 33: 948-952.
11. Suwa M, Seino Y, Nomachi Y, Matsuki S, Funahashi K. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy. Circ J 2005; 69: 283-290.
12. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
13. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002; 287: 628-640.
14. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Tavazzi L et al. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population. Eur Heart J 2006; 27: 2725-2736.
15. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 1987; 76: 115-124.
16. Hayashi M, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Tsutsui T, et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001; 37: 1820-1826.
17. Kosuge M, Miyajima E, Kimura K, Ishikawa T, Tochikubo O, Ishii M. Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction. Am J Cardiol 1998; 81: 781-784.
18. Elkayam U, Akhter MW, Singh H, Khan S, Usman A. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. Am J Cardiol 2004; 93: 237-240.
19. Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 2004; 110: 1620-1625.
20. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111: 1487-1491.